Cargando…
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology
Deregulation of the cholesterol pathway is an anomaly observed in human diseases, many of which have in common neurological involvement and unknown pathogenesis. In this study we have used Mevalonate Kinase Deficiency (MKD) as a disease-model in order to investigate the link between the deregulation...
Autores principales: | Marcuzzi, Annalisa, Piscianz, Elisa, Zweyer, Marina, Bortul, Roberta, Loganes, Claudia, Girardelli, Martina, Baj, Gabriele, Monasta, Lorenzo, Celeghini, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813225/ https://www.ncbi.nlm.nih.gov/pubmed/26978350 http://dx.doi.org/10.3390/ijms17030365 |
Ejemplares similares
-
Neuronal Dysfunction Associated with Cholesterol Deregulation
por: Marcuzzi, Annalisa, et al.
Publicado: (2018) -
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway
por: Marcuzzi, Annalisa, et al.
Publicado: (2015) -
MitoQ Is Able to Modulate Apoptosis and Inflammation
por: Piscianz, Elisa, et al.
Publicado: (2021) -
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis
por: Tricarico, Paola Maura, et al.
Publicado: (2013) -
To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies
por: Marcuzzi, Annalisa, et al.
Publicado: (2015)